Vimarsana
Biggest News Aggregation in the World

Page 8 - Rezolute Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rezolute Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rezolute Inc Today - Breaking & Trending Today

Granite Point Capital Management L.P. Sells 96,321 Shares of Rezolute, Inc. (NASDAQ:RZLT) - Vimarsana News

Granite Point Capital Management L.P. Sells 96,321 Shares of Rezolute, Inc. (NASDAQ:RZLT)

Granite Point Capital Management L.P. reduced its stake in Rezolute, Inc. (NASDAQ:RZLT – Get Rating) by 32.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 198,544 shares of the company’s stock after selling 96,321 shares during the period. Granite Point […]

Rezolute (NASDAQ:RZLT) Receives "Buy" Rating from HC Wainwright - Vimarsana News

Rezolute (NASDAQ:RZLT) Receives "Buy" Rating from HC Wainwright

HC Wainwright reissued their buy rating on shares of Rezolute (NASDAQ:RZLT – Get Rating) in a research report sent to investors on Tuesday, Benzinga reports. HC Wainwright currently has a $17.00 price objective on the stock. Separately, JMP Securities restated a market outperform rating and set a $8.00 target price on shares of Rezolute in […]

Rezolute KOL Event Highlights Significant Unmet Medical - Vimarsana News

Rezolute KOL Event Highlights Significant Unmet Medical

RZ402 is an oral therapy being developed as a potential alternative to anti-vascular growth factor (anti-VEGF) injections into the eye...

Rezolute KOL Event Highlights Significant Unmet Medical Need in Diabetic Macular Edema - Vimarsana News

Rezolute KOL Event Highlights Significant Unmet Medical Need in Diabetic Macular Edema

REDWOOD CITY, Calif., March 23, 2023 -- Rezolute, Inc. , a clinical-stage biopharmaceutical company dedicated to developing transformative therapies with the potential to shift the treatment... | March 23, 2023

Rezolute KOL Event Highlights Significant Unmet Medical Need in Diabetic Macular Edema - Vimarsana News

Rezolute KOL Event Highlights Significant Unmet Medical Need in Diabetic Macular Edema

RZ402 is an oral therapy being developed as a potential alternative to anti-vascular growth factor (anti-VEGF) injections into the eyeREDWOOD CITY, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceuti...